Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics. The company’s platform is in various parts of new drug discovery, developing novel platforms and screening systems for novel expanding, enhancing emotional health (E) ligases and for novel molecular glue degraders to address the unmet medical needs.
Investors 3
| Date | Name | Website |
| - | Korea Inve... | partners.k... |
| - | we venture... | en.weventu... |
| 06.02.2023 | Company K ... | kpartners.... |
Mentions in press and media 2
| Date | Title | Description |
| 24.11.2025 | Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial | Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation... |
| - | Pin Therapeutics | - |